Listed as one of Evidence Soup's 5 Links of the week, this report describes in detail how researchers, policymakers, and program administrators can recognize opportunities for experiments and carry them out. Specifically, the report focuses on opportunistic experiments, defined as randomized […]
Can Experimental Studies be More Like the Real World?
Clinical trials are great to prove effectiveness or safety, but what happens when real people in the real world are prescribed this medication? Does age make a difference? How about Comorbidities? Ultimately, we want to know what happens when the drug is used in routine clinical practice. The answer […]
EMA Explains Exceptions to Trial Transparency
In another step towards increasing the availability of clinical trial data, the European Medicines Agency's management board has approved a set of rules on the submission and publication of information through the new EU clinical trials portal and database, which are expected to be up and running […]
Check Out the New Issue of the Evidence Forum
The recent issue of the Evidence Forum includes a special interview: Establishing Health Technology Assessment in Russia: An Interview with Vitaly Omelyanovskiy. You can access this issue here, as well as archived issues. (Source: Evidera, October 2015) […]
DaVita Celebrates 30 Years of Pioneering Research
DaVita Clinical Research is celebrating 30 of pioneering clinical research Take a look at their journey with these key milestones over the last 30 years here. (Source: MarketWatch, 9/29/15) […]
What’s Next for Novartis?
dydforpharma Barcelona 2016 Keynote speaker David Epstein, CEO of Pharmaceuticals, Novartis sat down for an exclusive one-to-one in which he revealed what the future holds for Novartis. Find out more here. (Source: Paul Simms, […]
New Study Shows Intensive BP Management Could Save Your Life!
The U.S. National Institutes of Health recently released early findings from the Sprint Trial, a study of blood pressure management in people over 50. Does keeping systolic pressure below 120 reduce the cardiovascular disease and the risk of death? Find out here. (Source: […]
Mapi Responds to Growing Demand for eCOAs in Clinical Trials
Mapi Research Trust and CRF Health recently announced a collaboration to include eCOA solutions on PROQOLID. The growing demand for electronic clinical outcome assessments (eCOA) in clinical trials has created a significant need for this information. Read more here. (Source: PR Newswire, 9/8/15) […]
Another Failed Product – What Will GSK Do Now?
With GlaxoSmithKline's megablockbuster Advair soon to be experiencing fierce generic competition, investors were assured that the pharma giant had another remedy in hand. Excitement built around Breo Ellipta, a drug developed to improve the mortality rate of high-risk patients with COPD, but the […]
How Do Payers View Comparative Effectiveness and Relative Effectiveness Research?
A recently published paper in the International Journal of Technology Assessment in Health Care examined the views of payers in the United States and Europe on the rapidly evolving fields of comparative effectiveness and relative effectiveness research. See more here. (Source: OHE, 8/18/15) […]
Clinical Trials – How Can You Predict Patient Interest?
Health Union recently analyzed its proprietary data to examine factors involved in patients' interest and participation in clinical research. Report available here. (Source: Nassim Azzi, eyeforpharma) […]
Clinicaltrials.gov Leads to Frightening Discovery
A recent PLoS ONE study looking at reported clinical trial results, has shown a big change since the launch of the clinical trials.gov registry, with positive effect reports falling from 57% to a meager 8%. Read more here. (Source: Chris Woolston, nature.com, 8/13/15) […]
Good Practices for Reporting Numerical and Statistical Results
Hey, Researchers! Leave Those Bars Alone! is a short infographic showing good practices for reporting numerical and statistical results. See here. (Source: Aspire Scientific Ltd, The Publication Plan, 7/29/15) […]
Three Categories Influencing Clinical Trial Data Quality
This article builds on a previous article discussing how to define clinical trial data quality, and elaborates on three categories impacting clinical trial data quality. Read more here. (Source: Applied Clinical Trials, 7/20/15) […]
What Does the 21st Century Cures Mean for CROs?
Clinical Trials in the US are looking at a host of new provisions after a recent US House committee bill was passed. What impact will these provisions have on the way contract research organizations (CROs) operate? Find out here. (Source: Zachary Brennan, OutsourcingPharma.com, 6/17/15) […]
Drugmakers to Start Using Apple’s ResearchKit in Clinical Trails
GlaxoSmithKline (GSK) and Purdue Pharma are reportedly looking to integrate Apple's ResearchKit in clinical trials. Learn more about how ResearchKit is being used, here. (Source: Katie Bell, FirstWord Pharma, 7/13/15) […]
Big Data and the Effective Use of RWD are About to Transform R&D
RWDis useful in several phases of product development and is becoming crucial to decision making when used in conjunction with clinical trials. (Source: PMLiVE, 6/26/15) […]
Fraudulent Reports Dictating Worldwide Healthcare: How Big of a Problem is it?
Dr. Richard Horton, Editor-in-chief of the Lancet, recently published a statement declaring that a shocking amount of published research is unreliable at best, if not completely false, as in, fraudulent. Just how big of an issue is this really? The corruption of the medical industry worldwide is a […]
Check Out PAREXEL’s New Monitoring Capabilities
PAREXEL International Corporation recently launched next generation risk-based monitoring capabilities, expanding its Perceptive MyTrials Data-Driven Monitoring (DDM) solution. What will these enhancements do for drug developers? Find out here. (Source: PAREXEL, 6/18/15) […]
How do Policymakers View and Use CER?
Joel Weissman and colleagues recently had a study published in the Journal of Comparative Effectiveness Research. Their overarching question: How do senior coverage policymakers view and use CER? Find out what they learned and more here. (Source: AcademyHealth Blog, 6/15/15) […]
PPD and HealthCore Collaborate to Enhance Research Services
Pharmaceutical Product Development LLC (PPD) and HealthCore Inc recently announced a collaboration, enabling both companies to further expand their services in the pre- and post-approval research market with the aim of helping biopharmaceutical clients demonstrate more quickly and cost effectively […]
Why Are Drug Makers Hiding Reasons Behind Drug Rejections?
According to a new analysis, most pharmaceutical companies are not disclosing full details regarding FDA drug rejections - leaving patients and practitioners in the dark. Should pharmaceutical companies practice more transparency? Should the FDA change its regulations? Read more here. (Source: Ed […]
Is Your Clinical Trial Designed for Commercial Success?
FirstWord's report, Clinical Trial Design for Commercial Success, offers expert insights on how to best position drugs for success through strategic innovative design of clinical trials, and give new drugs every advantage in the marketplace. Available for purchase here. (Source: FirstWord, 6/2015) […]
CTI’s CEO Named Entrepreneur of the Year
CTI Clinical Trial and Consulting Services' CEO, Timothy Schroeder, was recently named EY Entrepreneur of the Year! Find out more about this prestigious award here! (Source: CTI, 6/16/15) […]
ERT Acquisition of PHT Now Complete
ERT recently announced the completed acquisition of PHT, positioning ERT as the leader in eClinical Outcome Assessments (eCOA) and patient-centric data collection. Learn more here. (Source: ERT, 5/11/15) […]
Patient Reported Outcomes – How Important is it to Use the Patient’s Own Words?
PatientsLikeMe has built its entire data scheme using patient-supplied symptoms, what they call the Patient Voice. This has helped tremendously to connect patients with one another, however it has proven to be quite a challenge when PatientsLikeMe, tried to use its data base to connect to the […]
Meet inVentiv Health experts at DIA
We are a global provider of best-in-class clinical development and comprehensive commercialization services to the biopharmaceutical industry. Visit us at the event: booth #1517. […]
Watson Group and Mayo Clinic – Matching Patients to Trials
Mayo Clinic and IBM's Watson group recently announced a collaboration to match Mayo oncology patients with the appropriate clinical trials. Read more here. (Source: Clinical Informatics News, 5/26/15) […]
Can Financial Assistance Increase Participation in Clinical Trials?
A new study takes a look at financial barriers for many cancer patients participating in clinical trials, and how financial assistance affects enrollment. More here. (Source: Academy of Managed Care Pharmacy) […]
How Big of a Game Changer is Immunotherapy for Cancer Care?
Researchers have long believed in the idea that the body's immune system had the potential to fight cancer, if only we could turn it against the disease. Today, some cancer patients are finding real success with immunotherapies, even after other treatments such as surgery, chemotherapy and radiation […]
